Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19

Condition:   COVID-19 Intervention:   Biological: bacTRL-Spike Sponsor:   Symvivo Corporation Not yet recruiting

Source: ClinicalTrials.gov - April 6, 2020 Category: Research Source Type: clinical trials